2-(5-fluoro-pentyl)-2-methyl-malonic-acid
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2008 (NCT00791063)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 2-(5-fluoro-pentyl)-2-methyl-malonic-acid
- ml-10
- ml-10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05534945 | N/A | Dec 31, 2022 | Ciusss de L'Est de l'Île de Montréal |
| NCT01260480 | Phase 2 | Dec 31, 2010 | Aposense Ltd., Tel Aviv University, University of Pittsburgh |
| NCT00805636 | Phase 2 | Nov 1, 2008 | Aposense Ltd. |
| NCT00696943 | Phase 2 | Jul 1, 2008 | Aposense Ltd. |
| NCT00791063 | Phase 2 | Mar 31, 2008 | Aposense Ltd. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aposense Ltd. | For profit | 4 | 4 | 1 | 2008 |
| Ciusss de L'Est de l'Île de Montréal | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Tel Aviv University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1